The previously used treatment approach for Crohn disease (CD) was to (1) initiate therapy with 5-aminosalicylate drugs such as mesalamine at diagnosis; (2) [...]; and (3) begin therapy with anti–tumor necrosis factor (anti-TNF) agents if these other therapies are unsuccessful.
Answer
begin thiopurine therapy with azathioprine or 6-mercaptopurine if a patient requires repeated courses of glucocorticoids
Question
The previously used treatment approach for Crohn disease (CD) was to (1) initiate therapy with 5-aminosalicylate drugs such as mesalamine at diagnosis; (2) [...]; and (3) begin therapy with anti–tumor necrosis factor (anti-TNF) agents if these other therapies are unsuccessful.
Answer
?
Question
The previously used treatment approach for Crohn disease (CD) was to (1) initiate therapy with 5-aminosalicylate drugs such as mesalamine at diagnosis; (2) [...]; and (3) begin therapy with anti–tumor necrosis factor (anti-TNF) agents if these other therapies are unsuccessful.
Answer
begin thiopurine therapy with azathioprine or 6-mercaptopurine if a patient requires repeated courses of glucocorticoids
If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open it The previously used treatment approach for Crohn disease (CD) was to (1) initiate therapy with 5-aminosalicylate drugs such as mesalamine at diagnosis; (2) begin thiopurine therapy with azathioprine or 6-mercaptopurine if a patient requires repeated courses of glucocorticoids; and (3) begin therapy with anti–tumor necrosis factor (anti-TNF) agents if these other therapies are unsuccessful.
Original toplevel document (pdf)
owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p2618
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.